Iron chelators for acute stroke.
CONCLUSIONS: We identified two eligible RCTs for assessment. We could not demonstrate any benefit for the use of iron chelators in spontaneous intracerebral haemorrhage. The added value of iron-chelating therapy in people with ischaemic stroke or subarachnoid haemorrhage remains unknown.
PMID: 33236783 [PubMed - in process]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Van der Loo LE, Aquarius R, Teernstra O, Klijn K, Menovsky T, van Dijk JMC, Bartels R, Boogaarts HD Tags: Cochrane Database Syst Rev Source Type: research
More News: Brain | Databases & Libraries | General Medicine | Hemorrhagic Stroke | Iron | Ischemic Stroke | Men | Neurology | Neuroscience | Science | Stroke | Study | Subarachnoid Hemorrhage